These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11368333)

  • 1. Characterization of cytochrome P450 2A4 and 2A5-catalyzed 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism.
    Felicia ND; Rekha GK; Murphy SE
    Arch Biochem Biophys; 2000 Dec; 384(2):418-24. PubMed ID: 11368333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
    Jalas JR; Ding X; Murphy SE
    Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of stereospecifically deuterated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) iastereomers and metabolism by A/J mouse lung microsomes and cytochrome p450 2A5.
    Jalas JR; Hecht SS
    Chem Res Toxicol; 2003 Jun; 16(6):782-93. PubMed ID: 12807362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific deuterium substitution attenuates the tumorigenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Jalas JR; McIntee EJ; Kenney PM; Upadhyaya P; Peterson LA; Hecht SS
    Chem Res Toxicol; 2003 Jun; 16(6):794-806. PubMed ID: 12807363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
    Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
    Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.
    Patten CJ; Peterson LA; Murphy SE
    Drug Metab Dispos; 1998 Feb; 26(2):177-80. PubMed ID: 9456305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine.
    Wong HL; Murphy SE; Hecht SS
    Chem Res Toxicol; 2005 Jan; 18(1):61-9. PubMed ID: 15651850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Nitrosobenzylmethylamine hydroxylation and coumarin 7-hydroxylation: catalysis by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes.
    von Weymarn LB; Felicia ND; Ding X; Murphy SE
    Chem Res Toxicol; 1999 Dec; 12(12):1254-61. PubMed ID: 10604876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of cytochrome P450 2A3-catalyzed alpha-hydroxylation of N'-nitrosonornicotine enantiomers.
    Murphy SE; Isaac IS; Ding X; McIntee EJ
    Drug Metab Dispos; 2000 Nov; 28(11):1263-6. PubMed ID: 11038149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of the tobacco carcinogen 4-(methylnitrosamino)-(3-pyridyl)-1-butanone by cytochrome P450 2A13 in human fetal nasal microsomes.
    Wong HL; Zhang X; Zhang QY; Gu J; Ding X; Hecht SS; Murphy SE
    Chem Res Toxicol; 2005 Jun; 18(6):913-8. PubMed ID: 15962925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides.
    Smith TJ; Stoner GD; Yang CS
    Cancer Res; 1995 Dec; 55(23):5566-73. PubMed ID: 7585636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.
    Brown PJ; Bedard LL; Reid KR; Petsikas D; Massey TE
    Drug Metab Dispos; 2007 Nov; 35(11):2086-94. PubMed ID: 17717079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.
    Miyazaki M; Yamazaki H; Takeuchi H; Saoo K; Yokohira M; Masumura K; Nohmi T; Funae Y; Imaida K; Kamataki T
    Carcinogenesis; 2005 Nov; 26(11):1947-55. PubMed ID: 15958517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6.
    Dicke KE; Skrlin SM; Murphy SE
    Drug Metab Dispos; 2005 Dec; 33(12):1760-4. PubMed ID: 16174803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificity in the gpt gene of AS52 cells.
    Tiano HF; Wang RL; Hosokawa M; Crespi C; Tindall KR; Langenbach R
    Carcinogenesis; 1994 Dec; 15(12):2859-66. PubMed ID: 8001247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes.
    Smith TJ; Liao AM; Liu Y; Jones AB; Anderson LM; Yang CS
    Carcinogenesis; 1997 Aug; 18(8):1577-84. PubMed ID: 9276633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
    Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS
    Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen.
    He XY; Shen J; Ding X; Lu AY; Hong JY
    Drug Metab Dispos; 2004 Dec; 32(12):1516-21. PubMed ID: 15333516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate.
    Smith TJ; Guo Z; Guengerich FP; Yang CS
    Carcinogenesis; 1996 Apr; 17(4):809-13. PubMed ID: 8625495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.